Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid schedules for BMD in prostate cancer patients on ADT
NCT00391950Phase 3Terminated
- Sponsor
- Novartis
- Start
- Oct 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Novartis. Started Oct 2006; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00391950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391950.